Código QR (código de barras bidimensional)

Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer

Abstract Background Amrubicin (AMR) regimens have shown efficacy as second‐line treatment in patients with small cell lung cancer (SCLC); however, adverse events such as febrile neutropenia (FN) sometimes preclude their use. Further, the safety and efficacy of AMR with primary prophylactic pegfilgra...

Fuld beskrivelse

Na minha lista:
Principais autores: Motoki Sekikawa, Haruyasu Murakami, Meiko Morita, Kosei Doshita, Keita Miura, Hiroaki Kodama, Noboru Morikawa, Yuko Iida, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Hirofumi Chiba, Toshiaki Takahashi
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2023-12-01
Serier:Thoracic Cancer
Fag:
amrubicin
febrile neutropenia
pegfilgrastim
second‐line chemotherapy
small cell lung cancer
Online adgang:https://doi.org/10.1111/1759-7714.15140
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker